A major 2026 trend in the animal health sector is the mainstream adoption of monoclonal antibody (mAb) therapy for chronic conditions like osteoarthritis and atopic dermatitis. In 2026, the market is identifying "mAbs for Pets" as a critical value-shifter for the Veterinary Biologics Market, offering a safer, long-acting alternative to traditional daily pills. This 2026 movement is critical...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
china 
thai
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)